Alectinib
CAS No. 1256580-46-7
Alectinib ( CH5424802;AF-802;CH 5424802;AF802;AF 802 )
产品货号. M11051 CAS No. 1256580-46-7
A potent, selective ALK inhibitor with IC50 of 1.9 nM; shows high selectivity versus KDR, KIT and MET (IC50>1,400 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥316 | 有现货 |
|
5MG | ¥510 | 有现货 |
|
10MG | ¥640 | 有现货 |
|
50MG | ¥867 | 有现货 |
|
100MG | ¥1385 | 有现货 |
|
200MG | ¥2211 | 有现货 |
|
500MG | ¥3718 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Alectinib
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A potent, selective ALK inhibitor with IC50 of 1.9 nM; shows high selectivity versus KDR, KIT and MET (IC50>1,400 nM).
-
产品描述A potent, selective ALK inhibitor with IC50 of 1.9 nM; shows high selectivity versus KDR, KIT and MET (IC50>1,400 nM); exhibits anti-proliferative activity against NPM-ALK-positive cellline KARPAS-299 with IC50 of 3 nM; also inhibits mutant ALK F1174L and R1275Q with IC50 of 1 nM and 3.5 nM respectively; orally active.Lung Cancer Approved
-
同义词CH5424802;AF-802;CH 5424802;AF802;AF 802
-
通路Angiogenesis
-
靶点ALK
-
受体ALK;ALK(F1174L);ALK(R1275Q);INSR;VEGFR2(KDR)
-
研究领域Cancer
-
适应症Lung Cancer
化学信息
-
CAS Number1256580-46-7
-
分子量482.62
-
分子式C30H34N4O2
-
纯度>98% (HPLC)
-
溶解度DMSO: 6.2 mg/mL (Need warming)
-
SMILESCCC1=C(C=C2C(=C1)C(=O)C1=C(NC3=C1C=CC(=C3)C#N)C2(C)C)N1CCC(CC1)N1CCOCC1
-
化学全称5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kinoshita K, et al. Bioorg Med Chem. 2012 Feb 1;20(3):1271-80.
2. Sakamoto H, et al. Cancer Cell. 2011 May 17;19(5):679-90.
3. Kodama T, et al. Mol Cancer Ther. 2014 Dec;13(12):2910-8.
2. Sakamoto H, et al. Cancer Cell. 2011 May 17;19(5):679-90.
3. Kodama T, et al. Mol Cancer Ther. 2014 Dec;13(12):2910-8.
产品手册
关联产品
-
Alectinib
A potent, selective ALK inhibitor with IC50 of 1.9 nM; shows high selectivity versus KDR, KIT and MET (IC50>1,400 nM).
-
LDN193189 hydrochlor...
LDN193189 is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM.
-
NVP-TAE 684
A highly potent and selective, orally available ALK inhibitor with IC50 of 3 nM in cell-free assays.